Redeye: Lagercrantz Q2 - Buyers Market
Redeye retains its positive take on Lagercrantz following a solid Q2. We believe Lagercrantz has handled a volatile market environment well and taken advantage of the lower prices for acquisitions. We think Lagercrantz will reach its SEK 1bn EBT target in the next twelve to eighteen months.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking.